The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia
Open accessAbstract
Limited data on the clinical outcome of vancomycin treatment compared with that of beta-lactam treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia (MSSA-B) are available. We used different and complementary approaches: (i) a retrospective cohort study using a propensity score to adjust for confounding by treatment assignment and (ii) a matched case-control study. Of all patients with S. aureus bacteremia (SAB) in two university-affiliated hospitals over a 7-year period, 294 patients with MSSA-B were enrolled in the cohort study. The cases for the case-control study were defined as patients who received vancomycin treatment for MSSA-B; the controls, who were patients that received beta-lactam treatment for MSSA-B, were selected at a 1:2 (case:control) ratio according to the objective matching scoring system and the propensity score system. In the cohort study, SAB-related mortality in patients with vancomycin treatment (37%, 10/27) was significantly higher than that in those with beta-lactam treatment (18%, 47/267) (P= 0.02). In addition, multivariate analysis revealed that vancomycin treatment was associated with SAB-related mortality when independent predictors for SAB-related mortality and propensity score were considered (adjusted odds ratio of 3.3, 95% confidence interval of 1.2 to 9.5). In the case-control study using the objective matching scoring system and the propensity score system, SAB-related mortality in case patients was 37% (10/27) and in control patients 11% (6/54) (P< 0.01). Our data suggest that vancomycin is inferior to beta-lactam in the treatment of MSSA-B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Surgical wound infection rates by wound class, operative procedure, and patient risk index
Culver, D. H., Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., Emori, T. G., Banerjee, S. N., Edwards, J. R., Tolson, J. S., Henderson, T. S., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90361-z · Cited by 1,601
The staphylococci in human disease
Crossley, K., & Archer, G. L. (1996) · Churchill Livingstone eBooks · Cited by 632
Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
Gonzalez, C., Rubio, M., Romero-Vivas, J., Gonzalez, M., & Picazo, J. J. (1999) · Clinical Infectious Diseases · doi:10.1086/313440 · Cited by 407
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Stryjewski, M. E., Szczech, L. A., Benjamin, D. K., Inrig, J. K., Kanafani, Z. A., Engemann, J. J., Chu, V. H., Joyce, M. J., Reller, L. B., Corey, G. R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510386 · Cited by 348
LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284
Harbarth, S., Rutschmann, O., Sudre, P., & Pittet, D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.2.182 · Cited by 267
Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia
Soriano, A., Martinez, J. A., Mensa, J., Marco, F., Almela, M., Moreno-Martinez, A., Sanchez, F., Munoz, I., Jimenez de Anta, M. T., & Soriano, E. (2000) · Clinical Infectious Diseases · doi:10.1086/313650 · Cited by 256
McGregor, J. C., Rich, S. E., Harris, A. D., Perencevich, E. N., Osih, R., Lodise, T. P., Miller, R. R., & Furuno, J. P. (2007) · Clinical Infectious Diseases · doi:10.1086/519283 · Cited by 194
Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome
Khatib, R., Johnson, L. B., Fakih, M. G., Riederer, K., Khosrovaneh, A., Shamse Tabriz, M., Sharma, M., & Saeed, S. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500372846 · Cited by 168
RecurrentStaphylococcus aureusBacteremia: Pulsed‐Field Gel Electrophoresis Findings in 29 Patients
Fowler, V. G., Kong, L., Corey, G. R., Gottlieb, G. S., McClelland, R. S., Sexton, D. J., Gesty‐Palmer, D., & Harrell, L. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314712 · Cited by 149
Outcome ofStaphylococcus aureusBacteremia in Patients with Eradicable Foci versus Noneradicable Foci
Kim, S., Park, W. B., Lee, K., Kang, C., Kim, H. B., Oh, M., Kim, E.-C., & Choe, K. W. (2003) · Clinical Infectious Diseases · doi:10.1086/377540 · Cited by 137
Self-citationKim, H. B., Park, W.-B., Lee, K.-D., Kang, C.-I., Bang, J.-W., Hong-Bin, K., Kim, E.-C., Oh, M.-D., & Kang-Won, C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh366 · Cited by 82
Self-citationKim, H. B., Park, W. B., Lee, J. H., Kang, C., Bang, J.-W., Kim, H. B., Kim, N.-J., Kim, E.-C., Oh, M., & Choe, K. W. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01294.x · Cited by 78
Self-citationRetrospective Evaluation of Therapies for Staphylococcus aureus Endocarditis
Gentry, C. A., Rodvold, K. A., Novák, R., Hershow, R. C., & Naderer, O. J. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03788.x · Cited by 72
Staphylococcus aureus Bacteremia and Endocarditis: The Role of Diagnostic Evaluation Erratum
Chang, F. ‐. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318282a722 · Cited by 30
Apellaniz, G., Valdés, M., Pérez, R., Martin, F., Soria, F., García, A. O., Gòmez, J., & Vicente, T. (1991) · Journal of Chemotherapy · doi:10.1080/1120009x.1991.11739072 · Cited by 19
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Clinical Management of Staphylococcus aureus Bacteremia: A Review
Holland, T. L., Arnold, C., & Fowler, V. G. (2014) · JAMA · doi:10.1001/jama.2014.9743 · Cited by 449
Bauer, K. A., West, J. E., Balada‐Llasat, J., Pancholi, P., Stevenson, K. B., & Goff, D. A. (2010) · Clinical Infectious Diseases · doi:10.1086/656623 · Cited by 347
Metadata
- Authors
- Kim, S.-H., Kim, K.-H., Kim, H.-B., Kim, N.-J., Kim, E.-C., Oh, M.-D., & Choe, K.-W.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-01
- Volume
- 52
- Issue
- 1
- Pages
- 192-197
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2117744797
- Cited by
- 300
- References
- 19
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.